Cargando…

Perspectives on interstitial photodynamic therapy for malignant tumors

Significance: Despite remarkable advances in the core modalities used in combating cancer, malignant diseases remain the second largest cause of death globally. Interstitial photodynamic therapy (IPDT) has emerged as an alternative approach for the treatment of solid tumors. Aim: The aim of our stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Komolibus, Katarzyna, Fisher, Carl, Swartling, Johannes, Svanberg, Sune, Svanberg, Katarina, Andersson-Engels, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Photo-Optical Instrumentation Engineers 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299827/
https://www.ncbi.nlm.nih.gov/pubmed/34302323
http://dx.doi.org/10.1117/1.JBO.26.7.070604
_version_ 1783726341553651712
author Komolibus, Katarzyna
Fisher, Carl
Swartling, Johannes
Svanberg, Sune
Svanberg, Katarina
Andersson-Engels, Stefan
author_facet Komolibus, Katarzyna
Fisher, Carl
Swartling, Johannes
Svanberg, Sune
Svanberg, Katarina
Andersson-Engels, Stefan
author_sort Komolibus, Katarzyna
collection PubMed
description Significance: Despite remarkable advances in the core modalities used in combating cancer, malignant diseases remain the second largest cause of death globally. Interstitial photodynamic therapy (IPDT) has emerged as an alternative approach for the treatment of solid tumors. Aim: The aim of our study is to outline the advancements in IPDT in recent years and provide our vision for the inclusion of IPDT in standard-of-care (SoC) treatment guidelines of specific malignant diseases. Approach: First, the SoC treatment for solid tumors is described, and the attractive properties of IPDT are presented. Second, the application of IPDT for selected types of tumors is discussed. Finally, future opportunities are considered. Results: Strong research efforts in academic, clinical, and industrial settings have led to significant improvements in the current implementation of IPDT, and these studies have demonstrated the unique advantages of this modality for the treatment of solid tumors. It is envisioned that further randomized prospective clinical trials and treatment optimization will enable a wide acceptance of IPDT in the clinical community and inclusion in SoC guidelines for well-defined clinical indications. Conclusions: The minimally invasive nature of this treatment modality combined with the relatively mild side effects makes IPDT a compelling alternative option for treatment in a number of clinical applications. The adaptability of this technique provides many opportunities to both optimize and personalize the treatment.
format Online
Article
Text
id pubmed-8299827
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Society of Photo-Optical Instrumentation Engineers
record_format MEDLINE/PubMed
spelling pubmed-82998272021-07-27 Perspectives on interstitial photodynamic therapy for malignant tumors Komolibus, Katarzyna Fisher, Carl Swartling, Johannes Svanberg, Sune Svanberg, Katarina Andersson-Engels, Stefan J Biomed Opt Perspectives Significance: Despite remarkable advances in the core modalities used in combating cancer, malignant diseases remain the second largest cause of death globally. Interstitial photodynamic therapy (IPDT) has emerged as an alternative approach for the treatment of solid tumors. Aim: The aim of our study is to outline the advancements in IPDT in recent years and provide our vision for the inclusion of IPDT in standard-of-care (SoC) treatment guidelines of specific malignant diseases. Approach: First, the SoC treatment for solid tumors is described, and the attractive properties of IPDT are presented. Second, the application of IPDT for selected types of tumors is discussed. Finally, future opportunities are considered. Results: Strong research efforts in academic, clinical, and industrial settings have led to significant improvements in the current implementation of IPDT, and these studies have demonstrated the unique advantages of this modality for the treatment of solid tumors. It is envisioned that further randomized prospective clinical trials and treatment optimization will enable a wide acceptance of IPDT in the clinical community and inclusion in SoC guidelines for well-defined clinical indications. Conclusions: The minimally invasive nature of this treatment modality combined with the relatively mild side effects makes IPDT a compelling alternative option for treatment in a number of clinical applications. The adaptability of this technique provides many opportunities to both optimize and personalize the treatment. Society of Photo-Optical Instrumentation Engineers 2021-07-23 2021-07 /pmc/articles/PMC8299827/ /pubmed/34302323 http://dx.doi.org/10.1117/1.JBO.26.7.070604 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/Published by SPIE under a Creative Commons Attribution 4.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI.
spellingShingle Perspectives
Komolibus, Katarzyna
Fisher, Carl
Swartling, Johannes
Svanberg, Sune
Svanberg, Katarina
Andersson-Engels, Stefan
Perspectives on interstitial photodynamic therapy for malignant tumors
title Perspectives on interstitial photodynamic therapy for malignant tumors
title_full Perspectives on interstitial photodynamic therapy for malignant tumors
title_fullStr Perspectives on interstitial photodynamic therapy for malignant tumors
title_full_unstemmed Perspectives on interstitial photodynamic therapy for malignant tumors
title_short Perspectives on interstitial photodynamic therapy for malignant tumors
title_sort perspectives on interstitial photodynamic therapy for malignant tumors
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299827/
https://www.ncbi.nlm.nih.gov/pubmed/34302323
http://dx.doi.org/10.1117/1.JBO.26.7.070604
work_keys_str_mv AT komolibuskatarzyna perspectivesoninterstitialphotodynamictherapyformalignanttumors
AT fishercarl perspectivesoninterstitialphotodynamictherapyformalignanttumors
AT swartlingjohannes perspectivesoninterstitialphotodynamictherapyformalignanttumors
AT svanbergsune perspectivesoninterstitialphotodynamictherapyformalignanttumors
AT svanbergkatarina perspectivesoninterstitialphotodynamictherapyformalignanttumors
AT anderssonengelsstefan perspectivesoninterstitialphotodynamictherapyformalignanttumors